Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ebru Özdemir (Ankara, Turkey), Ebru Özdemir, Esra Karabiber, Gül Karakaya, A. Fuat Kalyoncu. New indication of the conventional treatment for asthma: chronic idiopathic urticaria. Eur Respir J 2015; 46: Suppl. 59, 4022

Member's Comments

No comment yet.

Related content which might interest you: Association of allergy with chronic sinusitis in children Source: International Congress 2014 – Clinical allergy Year: 2014 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Fungal sensitization in patients with moderate and severe asthma Source: International Congress 2014 – Clinical allergy Year: 2014 Unexpected severe systemic allergic reaction after hymenoptera sting in well controlled asthma during treatment with omalizumab Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Serious asthma exacerbations in a hospital setting Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Total and free IgE in evolution of severe asthma after omalizumab treatment Source: International Congress 2016 – Asthma management Year: 2016 Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Predictors factors for asthma in patients with rhinitis Source: International Congress 2014 – Clinical allergy Year: 2014 Evaluating omalizumab persistency of response after long-term therapy (XPORT) Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry. Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Sublingual immunotherapy among patients, suffering from allergic rhinitis Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 The impact of psychological distress on allergic rhinitis and asthma control Source: International Congress 2014 – Asthma: clinical problems Year: 2014